Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities CommissionPR Newswire•10/09/2026•21:001 ShareWhiz InsightsGenerateNo content available.
